We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
(-46%)
Cap. Flow
-$438M
Cap. Flow
% of AUM
-78.37%
Top 10 Holdings %
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$25.1M |
| 2 |
Merck
MRK
|
+$9.57M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$9.37M |
| 4 |
BridgeBio Pharma
BBIO
|
+$9.02M |
| 5 |
Marvell Technology
MRVL
|
+$7.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
| 2 |
Citigroup
C
|
+$10.5M |
| 3 |
Microsoft
MSFT
|
+$9.87M |
| 4 |
OPTU
Optimum Communications Inc
OPTU
|
+$9.41M |
| 5 |
AES
AES
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.93% |
| 2 | Consumer Discretionary | 17.95% |
| 3 | Healthcare | 12.14% |
| 4 | Communication Services | 8.7% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Viatris
VTRS
$20.6B
| $1.39M | 0.25% |
+102,680
| New | +$1.37M |
|
127
Johnson Controls International
JCI
$93.1B
| $1.36M | 0.24% |
+16,779
| New | +$1.27M |
|
128
Aon
AON
$76.4B
| $1.36M | 0.24% |
+4,527
| New | +$1.36M |
|
129
Antero Resources
AR
$10.6B
| $1.36M | 0.24% |
77,638
+36,956
| +91% | +$700K |
|
130
Teva Pharmaceuticals
TEVA
$40.5B
| $1.35M | 0.24% |
169,197
-164,524
| -49% | -$1.48M |
|
|
P
131
Everpure Inc
P
$27.8B
| $1.35M | 0.24% |
41,572
-68,663
| -62% | -$1.99M |
|
|
AVLR
132
DELISTED
Avalara, Inc.
AVLR
| $1.35M | 0.24% |
+10,459
| New | +$1.63M |
|
|
DOCU
133
DocuSign
DOCU
$11B
| $1.35M | 0.24% |
+8,851
| New | +$2.02M |
|
134
Ross Stores
ROST
$81.2B
| $1.34M | 0.24% |
+11,769
| New | +$1.32M |
|
135
BHP
BHP
$227B
| $1.32M | 0.24% |
24,487
-87,176
| -78% | -$4.36M |
|
136
GSK
GSK
$103B
| $1.32M | 0.24% |
+23,913
| New | +$1.24M |
|
137
Corning
GLW
$135B
| $1.28M | 0.23% |
34,433
-68,308
| -66% | -$2.56M |
|
|
BBBY
138
Bed Bath & Beyond
BBBY
$440M
| $1.27M | 0.23% |
+23,671
| New | +$1.79M |
|
139
Corteva
CTVA
$52.5B
| $1.25M | 0.22% |
26,491
-29,861
| -53% | -$1.36M |
|
140
Intuitive Surgical
ISRG
$133B
| $1.22M | 0.22% |
+3,402
| New | +$1.17M |
|
141
MGM Resorts International
MGM
$11.4B
| $1.21M | 0.22% |
26,974
+7,669
| +40% | +$344K |
|
142
Stem
STEM
$52M
| $1.2M | 0.22% |
+3,174
| New | +$1.38M |
|
143
United Natural Foods
UNFI
$2.91B
| $1.2M | 0.21% |
+24,375
| New | +$1.18M |
|
|
SGI
144
Somnigroup International
SGI
$14.6B
| $1.2M | 0.21% |
25,414
+10,966
| +76% | +$497K |
|
145
Dynatrace
DT
$14.8B
| $1.17M | 0.21% |
19,335
+11,331
| +142% | +$772K |
|
146
Carrier Global
CARR
$53.9B
| $1.16M | 0.21% |
21,438
-76,843
| -78% | -$4.15M |
|
147
PayPal
PYPL
$49.6B
| $1.16M | 0.21% |
6,130
-32,618
| -84% | -$7.06M |
|
|
NKLA
148
DELISTED
Nikola Corporation Common Stock
NKLA
| $1.15M | 0.21% |
+3,872
| New | +$1.29M |
|
149
Lemonade
LMND
$4.03B
| $1.14M | 0.2% |
+27,029
| New | +$1.52M |
|
|
ETWO
150
DELISTED
E2open Parent Holdings
ETWO
| $1.13M | 0.2% |
+100,723
| New | +$1.18M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.
- Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
- Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
- Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
- Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
- Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
- Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
- Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.
Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.